spironolactone has been researched along with Cardiac Rupture, Post-Infarction in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eplerenone (Inspra) is a selective aldosterone blocker." | 6.43 | Eplerenone : a pharmacoeconomic review of its use in patients with post-myocardial infarction heart failure. ( Croom, KF; Plosker, GL, 2005) |
| "Eplerenone (Inspra) is a selective aldosterone blocker." | 2.43 | Eplerenone : a pharmacoeconomic review of its use in patients with post-myocardial infarction heart failure. ( Croom, KF; Plosker, GL, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croom, KF | 1 |
| Plosker, GL | 1 |
1 review available for spironolactone and Cardiac Rupture, Post-Infarction
| Article | Year |
|---|---|
Eplerenone : a pharmacoeconomic review of its use in patients with post-myocardial infarction heart failure.
Topics: Aged; Cost-Benefit Analysis; Economics, Pharmaceutical; Eplerenone; Female; Heart Failure; Heart Rup | 2005 |